Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study

BACKGROUND: Shorter duration of infusion of monoclonal antibody treatments may reduce treatment burden and improve healthcare resource utilization. METHODS: This phase II study recruited Japanese patients with previously untreated CD20+ B-cell non-Hodgkin lymphoma. Patients received intravenous obin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Jpn J Clin Oncol
Hoofdauteurs: Ohmachi, Ken, Ando, Kiyoshi, Kinoshita, Tomohiro, Kumagai, Kyoya, Hatake, Kiyohiko, Ishikawa, Takayuki, Teshima, Takanori, Kato, Koji, Izutsu, Koji, Ueda, Eisuke, Nakai, Kiyohiko, Kuriki, Hiroshi, Tobinai, Kensei
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2018
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6057540/
https://ncbi.nlm.nih.gov/pubmed/30060000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyy087
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items